Peer Review History
| Original SubmissionMay 5, 2020 |
|---|
|
PONE-D-20-13180 A qualitative exploration of using financial incentives to improve vaccination uptake in adolescents PLOS ONE Dear Dr. Forster, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. While I think the exploration of using financial incentives to improve vaccination uptake in adolescents is an important topic that warrants investigation, especially in the era of anti-vaccination trends all over the world, there are several issues with both the study design, and the manuscript itself that are significant enough that they seriously undermine the contributions of the study. The manuscript has a number of weaknesses, described by both reviewers, which need to be considered. The PLOS ONE publishes research on the basis of scientific validity and rigorous methodology. Together with the reviewers I have a number of reservations about this paper regarding both above mentioned issues. They are outlined below. Firstly, the manuscript title does not adequately reflect the study background and should be reworded. The abstract should include some important demographic variables, i.e. setting of study, age range of the participants, and specification regarding female secondary students (instead of “adolescents”). The Introduction section is should be shortened; some information on vaccine coverage in the country/at the study site should be provided, together with quantification of the problem caused by non-return of consent forms. Sampling criteria should be thoroughly described, possibly with the help of graph. Table of demographics for the two studies should be included. More detailed information of the rest of the cohort would be of value. References are presented in a sloppy way, this should be changed following the journal criteria. Please submit your revised manuscript by 19.07.20. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Prof. Maria Gańczak Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information 3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you very much for allowing me the opportunity to review the manuscript titled "A qualitative exploration of using financial incentives to improve vaccination uptake in adolescents" (PONE-D-20-13180). I felt confident that the authors performed careful and thorough analysis of the interesting data, however I feel like the manuscript has some errors that make it more difficult to read. I have a few comments and questions in regard to the paper; therefore I recommend that a minor revision is warranted. Please see some specific comments below. Title: Authors should be more specific in title – including that the participant cohort were only female and the setting took place in London, UK. Moreover, throughout the whole manuscript, it was emphasized that incentives were used to improve consent form return rate. “A qualitative exploration of using financial incentives to improve vaccination consent form return rate in female adolescents in London, UK.” Abstract: Include setting of study, age range of the participants, and specify they are female secondary students instead of “adolescents” for both study 1 and 2 under methods section. Introduction: Line 52 – It would be informative for readers if the decline of uptake in England was quantified Line 53 – similarly, it would also be informative for readers if the size of the 2018 measles outbreak was also quantified – how many were ill? Line 56 – Would be clearer to read if “In the UK programmes” was clarified to “In school-based vaccination programmes in the UK...” Line 58 - Authors said “consent forms must be returned” but in next sentence, it is said that “large proportions of consent form are not returned” which is contradicting, I would rephrasing those two sentences. It would be helpful to have confirmed that unreturned consent forms are considered consent declined. Line 73 – extra parentheses after 8, 9 citations Line 73 – “Most commonly they are operationalised as the offer of a reward by someone other than the target individual, although individuals may self-incentivise” It would be helpful for understanding of this sentence by providing readers of example. Line 93 – within the cited study, was the 76% compared to 61% vaccine uptake in cohorts found as a statistically significant difference? Line 96 – include “vaccination” between “Hepatitis B” and “consent forms” Line 149 – change to “the objectives of the paper are” as there are two objectives Methods and Materials Line 159 – “In brief, participants were six secondary schools in two London boroughs” is not clear Line 258 – “themes in Study and 2” unclear Line 263 – Either bring up Table 1 closer to paragraph end or specify that Table 1 in Results section Results It would be informative to have a table of demographics for the two studies. For example, line 274 mentions 37% of whom reported to be White British ethnic background. It would be informative for readers to have more detail of the rest of the cohort, as well as the other information collected like religion, birthplace and vaccination uptake within the previous feasibility study. Line 278 – “eight had received no doses of the vaccine” does this mean that they have declined consent to be vaccinated? Line 324 – would not consider “commonly expressed” with 18% of responses Table 1 – It would be useful to have a more specific table title, in case the table would stand alone. Example, to add this is from Study 2. Table 2 – Would also be useful to specify that this is for Study 1 Line 369 – Do not understand in quotation “Get for a vaccination” Table 3 – add in title from Study 1 quotes and Study 2 free text responses Discussion Line 524 – important that authors have noted that most participants in study were from families with low levels of socio-economic disadvantage – would be interesting to have study of a mixed cohort population and compare findings References Authors should review references list to standardize the way journal names – in some, journal names are all capitalised, some only sentence case, and some have short form of the journal Reviewer #2: This is a well written manuscript that is easy to follow. I’m not expert in qualitative research, but the reporting is clear and framed by the COREQ recommendations. Abstract: Mention that the studies included 12-13 and 13-14 year old girls in London Introduction: Well written and informative, but appears to be too long L 49-53 could be deleted to shorten the introduction, as the information is quite/too general On the other hand, some information on vaccine coverage in the UK / in London / in the included neighbourhoods would be helpful, and some quantification of the problem caused by non-return of consent forms. Methods: Please describe how schools were selected for participation Line 258: drop “and” Results: Line 284: “The most commonly reported religion was Christianity (50%) “=> rather say “Christianity was reported by half” Was there any information about who is responsible for the form not being returned: is this really the adolescents’ choice (which the verbatims seems to suggest), or do the parents have a substantial contribution to the fact that the form is not returned (refusal to sign, loss, etc). Discussion: Is there evidence that the acceptability is similar among parents (incentive to adolescents)? Which are the alternatives to incentivisation? Could the schools make the return of forms mandatory, just as other forms must be returned? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
A qualitative exploration of using financial incentives to improve vaccination uptake via consent form return in female adolescents in London PONE-D-20-13180R1 Dear Dr. Forster, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Prof. Maria Gańczak Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for responding to the reviewer comments. I believe that the authors' changes have benefited the study and the manuscript is now prepared for publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No |
| Formally Accepted |
|
PONE-D-20-13180R1 A qualitative exploration of using financial incentives to improve vaccination uptake via consent form return in female adolescents in London Dear Dr. Forster: I’m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they’ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Maria Gańczak Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .